NASDAQ:CTSO

Cytosorbents Corporation Earning Date

USA |NASDAQ |USD

CTSO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 4, 2021 Sep 2021 $-0.11 $-0.11 $-0.02
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 4, 2021 Sep 2021 $11.29M $12.02M $10.55M

Cytosorbents Corporation's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 2021.

CTSO Earnings Date & History Chart

CTSO Earnings & Revenue Forecast

CTSO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.09 $-0.16 $-0.01
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.43 $-0.52 $-0.33
Dec 2022 6 $-0.14 $-0.54 $0.67

CTSO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.07 $-0.07 $-0.03
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.38 $-0.39 $-0.23
Dec 2022 0 / 1 $-0.07 $-0.06 $0.05

CTSO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $12.59M $9.58M $16.37M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $45.43M $41.30M $48.60M
Dec 2022 6 $64.24M $46.50M $103.29M

CTSO Earnings Date & Revenue History

CTSO Earnings History

|
Show More
Show More

CTSO Revenue History

|
Show More
Show More

Cytosorbents Corporation Next Earnings Date & Report

CTSO Next Earnings Date & Report Preview: Sep 2021 (FQ)

CTSO's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Cytosorbents Corporation's next quarterly earnings is $-0.11, with a low EPS estimation of $-0.16, and a high estimation of $-0.07.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $-0.09, the last 2 month trend is $-0.08, and the 3 month trend is $-0.04.

Based on 6 analysts, the average revenue estimation is $11.29M, with a low revenue estimation of $9.67M, and a high estimation of $12.59M.

Cytosorbents Corporation Previous Earnings Dates & Reports

CTSO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cytosorbents Corporation's previous earnings date was Aug 3, 2021 for its fiscal quarter ended Jun 30, 2021.

CTSO's earnings per share (EPS) was $-0.11, missing the consensus analysts forecast of $-0.05 by -129.17%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 10.00%, and lower than the same period a year before (Jun 2020) by 37.50%.

Revenues were $12.02M, worse than the forecast of $12.27M by -2.00%, up by 13.45% from the previous quarter , and up by 22.76% from the same period last year.

The company reported a net income of $-4.68M.

Free cash flow for the quarter was $-3.02M , compared to $-2.95M last quarter and $1.44M a year before.

CTSO ended the quarter with $13.26M in total debt, an increase of 1335.51% compared to the previous quarter, and a decrease of -12.30% compared to the same quarter a year before.

CTSO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cytosorbents Corporation's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.

CTSO's earnings per share (EPS) was $-0.21, beating the consensus analysts forecast of $-0.23 by -8.70% , and higher than the previous year's EPS (Dec 2019) by -65.00%.

Revenues were $41.00M, better than the forecast of $40.00M by 2.51%, and up by 64.35% from previous year's revenue.

The company reported a net income of $-7.84M.

Cytosorbents Corporation reported a free cash flow of $-7.29M for its fiscal year, compared to $-18.28M a year ago.

The company ended the fiscal year with $1.03M in total debt, a decrease of -93.35% compared to the previous year.